1SFI

High resolution structure of a potent, cyclic protease inhibitor from sunflower seeds

Summary for 1SFI

• Entry DOI: 10.2210/pdb1sfi/pdb
• Related PRD ID: PRD_001097
• Descriptor: TRYPSIN, Trypsin inhibitor 1, SULFATE ION, ... (5 entities in total)
• Functional Keywords: trypsin inhibitor, cyclic peptide, protease, bovine-trypsin, serine protease-inhibitor, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
• Biological source: Bos taurus (cattle); More
• Cellular location: Secreted, extracellular space: P00760
• Total number of polymer chains: 2
• Total formula weight: 25188.38

Authors

Luckett, S.,Garcia, R.S.,Barker, J.J.,Konarev, A.V.,Shewry, P.,Clarke, A.R.,Brady, R.L. (deposition date: 1998-12-16, release date: 1999-07-09, Last modification date: 2024-10-30)

Primary citation

Luckett, S.,Garcia, R.S.,Barker, J.J.,Konarev, A.V.,Shewry, P.R.,Clarke, A.R.,Brady, R.L.
High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds.
J.Mol.Biol., 290:525-533, 1999

PubMed Abstract: Proteinaceous serine proteinase inhibitors are widespread throughout the plant kingdom where they play an important role in protection against pests and pathogens. Here, we describe the isolation and characterisation of a novel 14 amino acid residue cyclic peptide from sunflower seeds, which is a potent inhibitor of trypsin (Ki=100 pM). The crystal structure of this peptide in complex with bovine beta-trypsin shows both sequence and conformational similarity with the trypsin-reactive loop of the Bowman-Birk family of serine proteinase inhibitors. This inhibitor, however, is unique in being monofunctional, cyclic and far shorter (14 amino acid residues) than inhibitors belonging to this family (typically 60-70 amino acid residues). The high potency of this peptide is likely to arise from the considerable structural rigidity achieved through its cyclic nature which is further stabilised by a single internal disulphide bond. This study helps delineate the minimal unit required for effective peptide inhibitors of serine proteinases, and will assist in the further design of inhibitors to this widespread class of enzymes.

PubMed: 10390350
DOI: 10.1006/jmbi.1999.2891

Experimental method

X-RAY DIFFRACTION (1.65 Å)